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Suppression of anti-tumor T cell responses by MDSC
remains a significant barrier in cancer immunotherapy.
Although several pathways have been characterized as
critical for MDSC-induced suppression, there are cur-
rently no therapies to globally and specifically inhibit
MDSC function. We postulate that identifying and inhi-
biting the central mediators of MDSC-regulatory activity
will overcome T cell suppression and increase the
efficacy of T cell-based immunotherapy in cancer. We
aimed to determine the role of the common stress
sensor C/EBP-homologous-stress-related protein (Chop),
a downstream product of integrated stress responses, as
a master regulator of MDSC-suppressive activity. Our
results show that Chop is preferentially expressed in
malignant cells and MDSC in s.c. mouse tumors.
Selective expression of Chop was also detected in
tumor-infiltrating MDSC from colon carcinoma patients.
Interestingly, injection of tumor cells having functional
Chop into systemic Chop -/- mice or Chop null bone
marrow chimeric mice resulted in a significant anti-
tumor effect mediated by CD8+ T cells, suggesting the
importance of MDSC-Chop in tumor-induced tolerance.
In fact, deletion of Chop in MDSC increased the efficacy
of T cell-based immunotherapy. MDSC isolated from
tumor-bearing Chop null mice had decreased ability to
block T cell responses; impaired expression of major
MDSC-inhibitory pathways; and a surprising ability to
prime T cell proliferation and induce anti-tumor effects.
Accordingly, depletion of Gr-1+ MDSC restored tumor
growth in Chop -/- mice, while it prevented tumor
growth in wild type mice, confirming functional differ-
ences in MDSC from wild type and Chop -/- mice. To
therapeutically block Chop in tumors, we used a specific
liposomal-encapsulated siRNA, which successfully blocked
Chop expression and induced anti-tumor effects. We next
examined the effects of Chop on C/EBPb and STAT-3,
both master regulators of MDSC function. MDSC from
Chop -/- mice had elevated expression of C/EBPb inhibi-
tory isoform LIP, low C/EBPb binding to IL-6-promoter,
decreased IL-6 production, and impaired expression of
IL-6 target phospho-STAT-3. Also, Chop -/- MDSC
expressed higher levels of miR-142-3p, a mi-RNA that
promotes C/EBPb LIP over LAP and LAP*. Ectopic
expression of IL-6 in tumors restored tumor growth,
MDSC suppression, and C/EBPb and phospho-STAT-3
levels in Chop -/- mice, suggesting the role of this pathway
in the effects induced by Chop deletion. Collectively, this
data suggests the role of Chop as a master regulator of
the immune inhibitory activity of MDSC and justify the
potential targeting of Chop as a way to restore protective
immunity in cancer.
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